93 related articles for article (PubMed ID: 7931142)
1. Transgenic mice as models of human immunodeficiency virus expression and related cellular effects.
Brady HJ; Pennington DJ; Dzierzak EA
J Gen Virol; 1994 Oct; 75 ( Pt 10)():2549-58. PubMed ID: 7931142
[No Abstract] [Full Text] [Related]
2. Mapping of the human immunodeficiency virus type 2 envelope glycoprotein CD4 binding region and fusion domain with truncated proteins expressed by recombinant vaccinia viruses.
Otteken A; Voss G; Hunsmann G
Virology; 1993 May; 194(1):37-43. PubMed ID: 8480426
[TBL] [Abstract][Full Text] [Related]
3. Stable expression of the transfected HIV-1 env gene in a human B cell line: characterization of gp120-expressing clones and immunobiological studies.
Ahmad A; Ladha A; Cohen EA; Menezes J
Virology; 1993 Feb; 192(2):447-57. PubMed ID: 8421893
[TBL] [Abstract][Full Text] [Related]
4. [High-level expression of human immunodeficiency virus type 1 gp120 protein in E. coli].
Bi L; Lei X; Zhu J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Jun; 12(2):136-8. PubMed ID: 12515191
[TBL] [Abstract][Full Text] [Related]
5. Functional mapping of the rev-responsive element of human immunodeficiency virus type 2 (HIV-2): influence of HIV-2 envelope-encoding sequences on HIV-1 gp120 expression in the presence or absence of Rev.
Paulous S; Emerman M; Keller R; Montagnier L; Cordonnier A
J Gen Virol; 1992 Jul; 73 ( Pt 7)():1773-80. PubMed ID: 1629702
[TBL] [Abstract][Full Text] [Related]
6. [Virology on AIDS and AIDS dementia complex].
Hoshino H
No To Shinkei; 1997 Jan; 49(1):39-49. PubMed ID: 9027901
[No Abstract] [Full Text] [Related]
7. [Lentiviruses and origin of HIV].
Kitamura T
Nihon Rinsho; 1993 Sep; 51 Suppl():103-10. PubMed ID: 8271372
[No Abstract] [Full Text] [Related]
8. [Subtype and sequence analysis of the C2-V3 region of gp120 genes among HIV-1 strains in Hubei province].
Li YW; Shao YM; Luo XG
Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Aug; 18(4):217-9. PubMed ID: 9812522
[TBL] [Abstract][Full Text] [Related]
9. Neuronal expression of human immunodeficiency virus type 1 env proteins in transgenic mice: distribution in the central nervous system and pathological alterations.
Berrada F; Ma D; Michaud J; Doucet G; Giroux L; Kessous-Elbaz A
J Virol; 1995 Nov; 69(11):6770-8. PubMed ID: 7474088
[TBL] [Abstract][Full Text] [Related]
10. Transgenic models to assess the neuropathogenic potential of HIV-1 proteins and cytokines.
Mucke L; Masliah E; Campbell IL
Curr Top Microbiol Immunol; 1995; 202():187-205. PubMed ID: 7587363
[No Abstract] [Full Text] [Related]
11. Complexity and dynamics of HIV-1 quasispecies.
Menzo S; Bagnarelli P; Monachetti A; Fiorelli L; Clementi M
J Biol Regul Homeost Agents; 2000; 14(1):4-6. PubMed ID: 10763883
[TBL] [Abstract][Full Text] [Related]
12. AIDS. Of mice, monkeys and men.
Groopman JE
Nature; 1991 Feb; 349(6310):568-9. PubMed ID: 2000132
[No Abstract] [Full Text] [Related]
13. [Etiopathogenesis of HIV infection].
Pérez Alvarez L
Arch Neurobiol (Madr); 1989; 52 Suppl 1():17-22. PubMed ID: 2700293
[TBL] [Abstract][Full Text] [Related]
14. Human chorionic gonadotropin hormone prevents wasting syndrome and death in HIV-1 transgenic mice.
De SK; Wohlenberg CR; Marinos NJ; Doodnauth D; Bryant JL; Notkins AL
J Clin Invest; 1997 Apr; 99(7):1484-91. PubMed ID: 9119991
[TBL] [Abstract][Full Text] [Related]
15. Genotypic variants of HIV-1 from peripheral blood and lungs of AIDS patients.
Alimohammadi A; Coker R; Miller R; Mitchell D; Williamson J; Clarke J
AIDS; 1997 May; 11(6):831-2. PubMed ID: 9143625
[No Abstract] [Full Text] [Related]
16. Small amino acid changes in the V3 loop of human immunodeficiency virus type 2 determines the coreceptor usage for CXCR4 and CCR5.
Isaka Y; Sato A; Miki S; Kawauchi S; Sakaida H; Hori T; Uchiyama T; Adachi A; Hayami M; Fujiwara T; Yoshie O
Virology; 1999 Nov; 264(1):237-43. PubMed ID: 10544150
[TBL] [Abstract][Full Text] [Related]
17. Growth failure and AIDS-like cachexia syndrome in HIV-1 transgenic mice.
Santoro TJ; Bryant JL; Pellicoro J; Klotman ME; Kopp JB; Bruggeman LA; Franks RR; Notkins AL; Klotman PE
Virology; 1994 May; 201(1):147-51. PubMed ID: 7909972
[TBL] [Abstract][Full Text] [Related]
18. Analysis of dominant-negative effects of mutant Env proteins of human immunodeficiency virus type 1.
Iwatani Y; Kawano K; Ueno T; Tanaka M; Ishimoto A; Ito M; Sakai H
Virology; 2001 Jul; 286(1):45-53. PubMed ID: 11448157
[TBL] [Abstract][Full Text] [Related]
19. Genotypic and phenotypic variation of HIV-1: impact on AIDS pathogenesis and vaccination.
Wolfs TF; Nara PL; Goudsmit J
Chem Immunol; 1993; 56():1-33. PubMed ID: 8383980
[No Abstract] [Full Text] [Related]
20. Primary HIV-1 R5 isolates from end-stage disease display enhanced viral fitness in parallel with increased gp120 net charge.
Repits J; Sterjovski J; Badia-Martinez D; Mild M; Gray L; Churchill MJ; Purcell DF; Karlsson A; Albert J; Fenyö EM; Achour A; Gorry PR; Jansson M
Virology; 2008 Sep; 379(1):125-34. PubMed ID: 18672260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
